Addressing key limitations in the study on DCIS response to neoadjuvant chemotherapy in TNBC
Saved in:
| Main Authors: | Janhavi Venkataraman, Kefah Mokbel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Breast |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625004837 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reaction to ‘addressing key limitations in the study on DCIS response to neoadjuvant chemotherapy in TNBC’
by: Eva L. Claassens, et al.
Published: (2025-06-01) -
Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01) -
PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy
by: Eunju Shin, et al.
Published: (2025-08-01) -
Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective
by: Mariam Rizk, et al.
Published: (2025-06-01) -
Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component
by: Roxanne A.W. Ploumen, et al.
Published: (2025-02-01)